Pl. Mottram et al., CARDIAC ALLOGRAFTS FROM IL-4 KNOCKOUT RECIPIENTS - ASSESSMENT OF TRANSPLANT ARTERIOSCLEROSIS AND PERIPHERAL TOLERANCE, The Journal of immunology (1950), 161(2), 1998, pp. 602-609
To study the role of IL-4 in tolerance induction and transplant arteri
osclerosis, BALB/c hearts were transplanted into C57BL/6J wild-type or
IL-4 knockout (IL-4(-/-)) recipients. A 30-day course of anti-CD4/8 m
Ab was used to induce long term graft survival. Primary graft survival
was 50% (5 of 10) in IL-4(-/-) recipients comparable to 63% (5 of 8)
in wild-type recipients. Mice with allografts surviving >80 days were
tested for tolerance by challenge with a second donor or third partly
(CBA) heart, Secondary donor-strain heart grafts survived >30 days, hu
t showed histologic evidence of ongoing alloimmune response. Third par
ty hearts rejected rapidly. Although immunostaining and P-32 BT-PCR as
says showed no differences in the mononuclear cell infiltration and T
cell activation between LL-4(-/-) and wild-type tolerant recipients, s
ome monokines (IL-12, TNF-alpha, and allograft inflammatory factor-1)
were up-regulated in grafts from IL-4-/- recipients. Computer-assisted
analysis of elastin-stained vessels revealed that the severity of vas
cular thickening (percentage of luminal occlusion, mean +/- SD, n = 32
9) was similar in grafts from IL-4(-/-) (63.7 +/- 16.9%) and wild-type
(69.5 +/- 17.6%) recipients. Thus, IL-4 deficiency did not alter prim
ary or secondary graft survival, infiltration, or vascular thickening,
The selective alterations in monokine expression suggests that altern
ative pathways are activated and may compensate in IL-4(-/-) mice.